The insulin-like growth factor system and cancer

Baxter, 2000, Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities, Am. J. Physiol. Endocrinol. Metab, 278, E967, 10.1152/ajpendo.2000.278.6.E967

Clemmons, 2001, Use of mutagenesis to probe IGF-binding protein structure/function relationships, Endocr. Rev, 22, 800, 10.1210/er.22.6.800

LeRoith, 1995, Molecular and cellular aspects of the insulin-like growth factor I receptor, Endocr. Rev, 16, 143, 10.1210/edrv-16-2-143

Daughaday, 1989, Insulin-like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations, Endocr. Rev, 10, 68, 10.1210/edrv-10-1-68

Rother, 2000, Role of insulin receptors and IGF receptors in growth and development, Pediatr. Nephrol, 14, 558, 10.1007/s004670000351

Frasca, 1999, Insulin receptor isoform A, a newly recognized, high-affinity insulin- like growth factor II receptor in fetal and cancer cells, Mol. Cell Biol, 19, 3278, 10.1128/MCB.19.5.3278

Pandini, 2002, Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved, J. Biol. Chem, 277, 39684, 10.1074/jbc.M202766200

White, 1994, The IRS-1 signaling system, Curr. Opin. Genet. Dev, 4, 47, 10.1016/0959-437X(94)90090-6

Khandwala, 2000, The effects of insulin-like growth factors on tumorigenesis and neoplastic growth, Endocr. Rev, 21, 215, 10.1210/er.21.3.215

Werner, 1996, Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene, Proc. Natl Acad. Sci. USA, 93, 8318, 10.1073/pnas.93.16.8318

Girnita, 2000, Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact, Cancer Res, 60, 5278

Tanno, 2001, AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells, Cancer Res, 61, 589

Garrouste, 2002, Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism, Cell Death Differ, 9, 768, 10.1038/sj.cdd.4401022

Cheshire, 1997, Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation, Mol. Cell Biol, 17, 6746, 10.1128/MCB.17.11.6746

Andre, 1999, Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells, Int. J. Cancer, 83, 497, 10.1002/(SICI)1097-0215(19991112)83:4<497::AID-IJC11>3.0.CO;2-D

Pennisi, 2002, Reduced expression of insulin-like growth factor-I receptors in mcf-7 breast cancer cells leads to a more metastatic phenotype, Cancer Res, 62, 6529

Satyamoorthy, 2001, Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways, Cancer Res, 61, 7318

Gilmore, 2002, Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor, J. Biol. Chem, 277, 27643, 10.1074/jbc.M108863200

Dupont, 2000, The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components, J. Biol. Chem., 275, 35893, 10.1074/jbc.M006741200

Dalle, 2001, Insulin and insulin-like growth factor I receptors utilize different G protein signaling components, J. Biol. Chem, 276, 15688, 10.1074/jbc.M010884200

Chakravarti, 2002, Insulin-like growth factor receptor I mediates resistance to anti- epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling, Cancer Res, 62, 200

Meyer, 2001, Insulin-like growth factor I stimulates motility in human neuroblastoma cells, Oncogene, 20, 7542, 10.1038/sj.onc.1204927

Satyamoorthy, 2002, Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction, Cell Growth Differ, 13, 87

Reinmuth, 2002, Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer, Clin. Cancer Res, 8, 3259

Scotlandi, 2002, Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells, Int. J. Cancer, 101, 11, 10.1002/ijc.10537

Pietrzkowski, 1993, Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1, Cancer Res, 53, 1102

D'Ambrosio, 1996, A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis, Cancer Res, 56, 4013

Favelyukis, 2001, Structure and autoregulation of the insulin-like growth factor 1 receptor kinase, Nat. Struct. Biol, 8, 1058, 10.1038/nsb721

Munshi, 2002, Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase: Implication for inhibitor specificity, J. Biol. Chem, 277, 38797, 10.1074/jbc.M205580200

Pautsch, 2001, Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation, Structure (Camb), 9, 955, 10.1016/S0969-2126(01)00655-4

DeMeyts, 2002, Structural biology of insulin and IGF1 receptors: implications for drug design, Nat. Rev. Drug Discov, 1, 769, 10.1038/nrd917

Cohen, 1998, Serum insulin-like growth factor-I levels and prostate cancer risk–interpreting the evidence, J. Natl Cancer Inst, 90, 876, 10.1093/jnci/90.12.876

Wolk, 1998, Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study, J. Natl Cancer Inst, 90, 911, 10.1093/jnci/90.12.911

Cohen, 1994, Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia, J. Clin. Endocrinol. Metab, 79, 1410, 10.1210/jc.79.5.1410

Cohen, 1994, The IGF axis in the prostate, Horm. Metab. Res, 26, 81, 10.1055/s-2007-1000777

Cohen, 1994, Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease, J. Endocrinol, 142, 407, 10.1677/joe.0.1420407

Torring, 1997, Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate, J. Urol, 158, 222, 10.1097/00005392-199707000-00075

Huynh, 1998, Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3, Cancer Res, 58, 215

Ruan, 1999, Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development, Endocrinology, 140, 1984, 10.1210/en.140.5.1984

Cutting, 1999, Serum insulin-like growth factor-1 is not a useful marker of prostate cancer, BJU Int, 83, 996, 10.1046/j.1464-410x.1999.00088.x

Djavan, 1999, Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection, Urology, 54, 603, 10.1016/S0090-4295(99)00280-0

Finne, 2000, Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen, J. Clin. Endocrinol. Metab, 85, 2744, 10.1210/jc.85.8.2744

Baffa, 2000, Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer, Tech. Urol, 6, 236

Harman, 2000, Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer, J. Clin. Endocrinol. Metab, 85, 4258, 10.1210/jc.85.11.4258

Stattin, 2000, Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study, J. Natl Cancer Inst, 92, 1910, 10.1093/jnci/92.23.1910

Hankinson, 1998, Circulating concentrations of insulin-like growth factor-I and risk of breast cancer, Lancet, 351, 1393, 10.1016/S0140-6736(97)10384-1

Vadgama, 1999, Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women, Oncology, 57, 330, 10.1159/000012052

Jernstrom, 1999, Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study, J. Womens Health Gend. Based Med, 8, 1265, 10.1089/jwh.1.1999.8.1265

Agurs-Collins, 2000, Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women, Cancer Detect Prev, 24, 199

Ma, 1999, Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3, J. Natl Cancer Inst, 91, 620, 10.1093/jnci/91.7.620

Palmqvist, 2002, Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden, Gut, 50, 642, 10.1136/gut.50.5.642

Probst-Hensch, 2001, IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai, Br. J. Cancer, 85, 1695, 10.1054/bjoc.2001.2172

Yu, 1999, Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis, J. Natl Cancer Inst, 91, 151, 10.1093/jnci/91.2.151

Lukanova, 2001, study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women, Int. J. Cancer, 92, 888, 10.1002/ijc.1265

Almeida, 1994, The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer, Genes Chromosomes Cancer, 11, 63, 10.1002/gcc.2870110110

DePinho, 2000, The age of cancer, Nature, 408, 248, 10.1038/35041694

Kaleko, 1990, Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation, Mol. Cell Biol, 10, 464, 10.1128/MCB.10.2.464

Turner, 1997, Glazer insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation, Cancer Res, 57, 3079

Wen, 2001, Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells, Br. J. Cancer, 85, 2017, 10.1054/bjoc.2001.2171

Tennant, 1996, Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium, J. Clin. Endocrinol. Metab, 81, 3774, 10.1210/jc.81.10.3774

Happerfield, 1997, The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue, J. Pathol, 183, 412, 10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4

Chott, 1999, Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor, Am. J. Pathol, 155, 1271, 10.1016/S0002-9440(10)65229-7

Schnarr, 2000, Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer, Int. J. Cancer, 89, 506, 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F

Damon, 2001, Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells, Endocrinology, 142, 21, 10.1210/en.142.1.21

Hellawell, 2002, Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease, Cancer Res, 62, 2942

Sperandio, 2002, An alternative, nonapoptotic form of programmed cell death, Proc. Natl Acad. Sci USA, 97, 14376, 10.1073/pnas.97.26.14376